18633108|t|Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population.
18633108|a|OBJECTIVE: Genome-wide association studies have identified common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, HHEX/IDE, EXT2, and LOC387761 loci that significantly increase the risk of type 2 diabetes. We aimed to replicate these observations in a population-based cohort of Chinese Hans and examine the associations of these variants with type 2 diabetes and diabetes-related phenotypes. RESEARCH DESIGN AND METHODS: We genotyped 17 single nucleotide polymorhisms (SNPs) in 3,210 unrelated Chinese Hans, including 424 participants with type 2 diabetes, 878 with impaired fasting glucose (IFG), and 1,908 with normal fasting glucose. RESULTS: We confirmed the associations between type 2 diabetes and variants near CDKAL1 (odds ratio 1.49 [95% CI 1.27-1.75]; P = 8.91 x 10(-7)) and CDKN2A/B (1.31 [1.12-1.54]; P = 1.0 x 10(-3)). We observed significant association of SNPs in IGF2BP2 (1.17 [1.03-1.32]; P = 0.014) and SLC30A8 (1.12 [1.01-1.25]; P = 0.033) with combined IFG/type 2 diabetes. The SNPs in CDKAL1, IGF2BP2, and SLC30A8 were also associated with impaired beta-cell function estimated by homeostasis model assessment of beta-cell function. When combined, each additional risk allele from CDKAL1-rs9465871, CDKN2A/B-rs10811661, IGF2BP2-rs4402960, and SLC30A8-rs13266634 increased the risk for type 2 diabetes by 1.24-fold (P = 2.85 x 10(-7)) or for combined IFG/type 2 diabetes by 1.21-fold (P = 6.31 x 10(-11)). None of the SNPs in EXT2 or LOC387761 exhibited significant association with type 2 diabetes or IFG. Significant association was observed between the HHEX/IDE SNPs and type 2 diabetes in individuals from Shanghai only (P < 0.013) but not in those from Beijing (P > 0.33). CONCLUSIONS: Our results indicate that in Chinese Hans, common variants in CDKAL1, CDKN2A/B, IGF2BP2, and SLC30A8 loci independently or additively contribute to type 2 diabetes risk, likely mediated through beta-cell dysfunction.
18633108	19	25	CDKAL1	Gene	54901
18633108	27	35	CDKN2A/B	Gene	1029;1030
18633108	37	44	IGF2BP2	Gene	10644
18633108	46	53	SLC30A8	Gene	169026
18633108	59	63	HHEX	Gene	3087
18633108	64	67	IDE	Gene	3416
18633108	94	109	type 2 diabetes	Disease	MESH:D003924
18633108	114	138	impaired fasting glucose	Disease	MESH:D007003
18633108	246	252	CDKAL1	Gene	54901
18633108	254	262	CDKN2A/B	Gene	1029;1030
18633108	264	271	IGF2BP2	Gene	10644
18633108	273	280	SLC30A8	Gene	169026
18633108	282	286	HHEX	Gene	3087
18633108	287	290	IDE	Gene	3416
18633108	292	296	EXT2	Gene	2132
18633108	357	372	type 2 diabetes	Disease	MESH:D003924
18633108	512	527	type 2 diabetes	Disease	MESH:D003924
18633108	532	540	diabetes	Disease	MESH:D003920
18633108	709	724	type 2 diabetes	Disease	MESH:D003924
18633108	735	759	impaired fasting glucose	Disease	MESH:D007003
18633108	761	764	IFG	Disease	MESH:D007003
18633108	797	804	glucose	Chemical	MESH:D005947
18633108	853	868	type 2 diabetes	Disease	MESH:D003924
18633108	887	893	CDKAL1	Gene	54901
18633108	954	962	CDKN2A/B	Gene	1029;1030
18633108	1048	1055	IGF2BP2	Gene	10644
18633108	1090	1097	SLC30A8	Gene	169026
18633108	1142	1145	IFG	Disease	MESH:D007003
18633108	1146	1161	type 2 diabetes	Disease	MESH:D003924
18633108	1175	1181	CDKAL1	Gene	54901
18633108	1183	1190	IGF2BP2	Gene	10644
18633108	1196	1203	SLC30A8	Gene	169026
18633108	1371	1377	CDKAL1	Gene	54901
18633108	1378	1387	rs9465871	SNP	tmVar:rs9465871;VariantGroup:1;CorrespondingGene:54901;RS#:9465871;CorrespondingSpecies:9606
18633108	1389	1397	CDKN2A/B	Gene	1029;1030
18633108	1398	1408	rs10811661	SNP	tmVar:rs10811661;VariantGroup:0;RS#:10811661
18633108	1410	1417	IGF2BP2	Gene	10644
18633108	1418	1427	rs4402960	SNP	tmVar:rs4402960;VariantGroup:2;CorrespondingGene:10644;RS#:4402960;CorrespondingSpecies:9606
18633108	1433	1440	SLC30A8	Gene	169026
18633108	1441	1451	rs13266634	SNP	tmVar:rs13266634;VariantGroup:3;CorrespondingGene:169026;RS#:13266634;CorrespondingSpecies:9606
18633108	1475	1490	type 2 diabetes	Disease	MESH:D003924
18633108	1540	1543	IFG	Disease	MESH:D007003
18633108	1544	1559	type 2 diabetes	Disease	MESH:D003924
18633108	1615	1619	EXT2	Gene	2132
18633108	1672	1687	type 2 diabetes	Disease	MESH:D003924
18633108	1691	1694	IFG	Disease	MESH:D007003
18633108	1745	1749	HHEX	Gene	3087
18633108	1750	1753	IDE	Gene	3416
18633108	1763	1778	type 2 diabetes	Disease	MESH:D003924
18633108	1942	1948	CDKAL1	Gene	54901
18633108	1950	1958	CDKN2A/B	Gene	1029;1030
18633108	1960	1967	IGF2BP2	Gene	10644
18633108	1973	1980	SLC30A8	Gene	169026
18633108	2028	2043	type 2 diabetes	Disease	MESH:D003924
18633108	2074	2095	beta-cell dysfunction	Disease	MESH:D007340
18633108	Association	MESH:D003924	54901
18633108	Association	MESH:D003924	1030
18633108	Association	MESH:D003924	2132
18633108	Positive_Correlation	MESH:D003924	RS#:10811661
18633108	Positive_Correlation	MESH:D007003	RS#:9465871;CorrespondingGene:54901
18633108	Association	MESH:D007003	169026
18633108	Association	MESH:D003924	3416
18633108	Association	MESH:D003924	10644
18633108	Association	MESH:D003924	169026
18633108	Association	MESH:D007003	54901
18633108	Association	MESH:D007003	1030
18633108	Association	MESH:D003924	1029
18633108	Association	MESH:D007003	3416
18633108	Association	MESH:D003924	3087
18633108	Positive_Correlation	MESH:D003924	RS#:9465871;CorrespondingGene:54901
18633108	Positive_Correlation	MESH:D003924	RS#:4402960;CorrespondingGene:10644
18633108	Association	MESH:D007003	10644
18633108	Association	MESH:D007003	1029
18633108	Association	MESH:D007003	3087
18633108	Association	MESH:D007003	54901
18633108	Association	MESH:D003924	54901
18633108	Association	MESH:D003924	10644

